Kronos Bio Inc (KRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,364 | -86,079 | -60,266 | -46,157 | -29,958 |
| Depreciation Amortization | 57 | -1,091 | -1,128 | -1,026 | -631 |
| Accounts payable and accrued liabilities | -832 | 1,523 | 400 | 111 | 1,347 |
| Other Working Capital | -7,778 | -17,893 | -12,627 | -11,887 | -7,796 |
| Other Operating Activity | 4,075 | 38,105 | 21,021 | 18,730 | 13,139 |
| Operating Cash Flow | $-12,842 | $-65,435 | $-52,600 | $-40,229 | $-23,899 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4 | N/A | -7 | -7 |
| Purchase Of Investment | -4,452 | -89,232 | -78,776 | -55,154 | -48,754 |
| Sale Of Investment | 24,300 | 174,671 | 141,851 | 101,107 | 54,531 |
| Investing Cash Flow | $19,848 | $85,435 | $63,075 | $45,946 | $5,770 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 245 | 163 | 164 | N/A |
| Financing Cash Flow | $N/A | $245 | $163 | $164 | $N/A |
| Beginning Cash Position | 86,597 | 66,352 | 66,352 | 66,352 | 66,352 |
| End Cash Position | 93,603 | 86,597 | 76,990 | 72,233 | 48,223 |
| Net Cash Flow | $7,006 | $20,245 | $10,638 | $5,881 | $-18,129 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,842 | -65,435 | -52,600 | -40,229 | -23,899 |
| Capital Expenditure | N/A | -4 | 0 | -7 | -7 |
| Free Cash Flow | -12,842 | -65,439 | -52,600 | -40,236 | -23,906 |